An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)

NCT07744113 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Bipolar 1 Disorder
Schizophrenia Disorder

Interventions

DRUG: OLZ/SAM

Sponsor

Alkermes, Inc.